GET THE APP

Different Kinds of Antibiotics and Role of Anibiotic-Resistant Bacteria

Different Kinds of Antibiotics and Role of Anibiotic-Resistant Bacteria

Opinion Article - (2022) Volume 6, Issue 5

E. Oliveira*
 
*Correspondence: E. Oliveira, Department of Sanitary and Environmental Engineering, Federal University of Minas Gerais, Av. Antônio, Brazil, Email:

Author info »

Description

Antibiotic-resistant bacteria is a growing problem worldwide. Infections from these so-called “superbugs” are difficult to treat and can often be deadly. There are a number of reasons why bacteria can become resistant to antibiotics. One is simply that they can mutate over time and develop new ways to survive the drugs. Another is that they can acquire resistance genes from other bacteria. There are a number of ways to combat antibiotic-resistant bacteria. One is to develop new antibiotics that are effective against them. Another is to improve hygiene and infection control measures to reduce the spread of these bacteria. However, the most important thing we can do is to use antibiotics wisely. That means using them only when necessary and taking steps to prevent the development of resistance in the first place.

The Different Types of Antibiotics includes Penicillin - This is a naturally occurring antibiotic that is derived from mold. It is effective against a wide range of bacteria, including streptococcus, staphylococcus, and gonococcus.

Cephalosporin - This group of antibiotics includes cephalothin, cefazolin, cephalexin, cefaclor, and cefuroxime. They are effective against a variety of bacteria, including streptococcus, staphylococcus, and gonococcus.

Macrolide - This group of antibiotics includes erythromycin, azithromycin, and clarithromycin. They are effective against a variety of bacteria, including streptococcus, staphylococcus, and gonococcus.

Tetracycline - This group of antibiotics includes tetracycline, doxycycline, and minocycline. They are effective against a variety of bacteria, including streptococcus, staphylococcus, and gonococcus.

Aminoglycoside - This group of antibiotics includes gentamicin, tobramycin, and amikacin. They are effective against a variety of bacteria, including streptococcus, staphylococcus, and gonococcus.

Fluoroquinolone - This group of antibiotics includes ciprofloxacin, levofloxacin, and ofloxacin. They are effective against a variety of bacteria, including streptococcus, staphylococcus, and gonococcus.

Antibiotic Spectrum Gram positives and Gram negatives are the two major types of pathogenic bacteria. Gram-positive bacteria retain a dye called crystal violet during Gram staining, giving them a purple appearance when viewed under a microscope. Gram-negative bacteria, on the other hand, do not stain with the purple dye during Gram staining, but do stain with another dye called safranin, which gives them a pink colour when viewed through a microscope. The cell envelopes of these two types of bacteria are fundamentally different. Gram negatives, in particular, have an outer and inner membrane as well as a thin cell wall, whereas Gram positives only have an inner membrane and a thick cell wall. As a result, their antibiotic uptake differs, and some antibiotics are more effective in one of these groups than the other. S. aureus, Streptococcus pyogenes, Enterococcus faecalis, and Clostridium botulinum are all Gram-positive bacteria that are human pathogens. E. coli, Salmonella enterica, Vibrio cholerae, and Pseudomonas aeruginosa are all Gram-negative bacteria that are human pathogens. M. tuberculosis is an important human pathogen that belongs to a third type of bacteria known as acid-fast. This organism has a waxy cell membrane/cell wall that retains a stain even when acid and alcohol are present. Mycobacteria are resistant to most antibiotics that kill Gram-positive or Gram-negative bacteria due to their waxy outer coating.

The future of antibiotics looks promising. Researchers are constantly searching for new and better ways to fight bacteria and other microorganisms. One promising area of research is the development of new antibiotics that are effective against a wider range of bacteria. Another area of research is the development of antibodies that can target specific bacteria. One of the biggest challenges facing the future of antibiotics is the development of resistance by bacteria. Bacteria are constantly evolving and may eventually develop resistance to even the most powerful antibiotics. Therefore, it is important for researchers to continue to develop new antibiotics and other strategies to combat resistance.

Despite the challenges, the future of antibiotics looks promising. With continued research, we may be able to develop new antibiotics that are even more effective than those currently available. With the advent of antibiotics, many diseases that were once deadly have become treatable. However, the overuse of antibiotics has led to the development of antibiotic-resistant strains of bacteria. In order to combat these resistant strains, scientists are constantly searching for new and improved antibiotics. In addition, the use of antibodies-proteins that bind to and neutralize foreign substances in the body-has become an important tool in the fight against infection. While antibiotics are still the front-line defense against bacteria, advances in both antibiotics and antibodies are needed to keep up with the ever-evolving threat of antibiotic-resistant bacteria.

Author Info

E. Oliveira*
 
Department of Sanitary and Environmental Engineering, Federal University of Minas Gerais, Av. Antônio, Brazil
 

Citation: E. Oliveira (2022) “Different Kinds of Antibiotics and Role of Antibiotic-Resistant Bacteria”. Adv Antibiot Antibod. vol.6, Article ID 101063, 2 pages, 2022. DOI: 10.11131/AAACTV-22/101063

Received Date: Oct 03, 2022 / Manuscript No: AAACTV-22-79154 / Editor Assigned: Oct 06, 2022 PreQC No: AAACTV-22-79154(PQ) / Reviewed Date: Oct 20, 2022 / QC No: AAACTV-22-79154 / Revised Date: Oct 27, 2022 Revised Manuscript No: AAACTV-22-79154(R) / Published Date: Nov 04, 2022 Doi: 10.11131/ AAACTV-22/101063

Copyright: © 2022 E. Oliveira. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.